Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
Clinical trial NCT06160791 · RECRUITING
Trial details
- NCT number
- NCT06160791
- Sponsor
- Jerry Lee, MD, MSc, MPhil
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2028-12-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.